NCT06411405

Brief Summary

The goal of this observational study is to develop a risk prediction model for early-onset neonatal sepsis in term and late preterm neonates in Uganda and Zimbabwe. The main questions it aims to answer are:

  • What are the risk factors for early-onset neonatal sepsis in low-resource settings?
  • How can these be combined into a risk prediction model? Mother-baby pairs will be recruited in Uganda. They will have extensive data taken on their medical and obstetric histories and lifestyles, and their newborns will have a blood sample taken just after birth for culture. Machine learning techniques will be used to create the risk prediction model, which will then be validated in a second population in Zimbabwe.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2024

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 13, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 17, 2024

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

April 17, 2024

Last Update Submit

May 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Positive blood culture amongst neonatal participants

    Venous blood culture processed on BACTEC machine

    Sample taken in first 48 hours of life

Secondary Outcomes (5)

  • Documented clinical diagnosis of sepsis amongst neonatal participants

    Within first 72 hours of life

  • Clinical features of neonatal sepsis

    Within first 72 hours of life

  • Admission to neonatal unit

    Within first 72 hours of life

  • Readmission to hospital in first 28 days amongst neonatal participants

    Within 28 days of birth

  • Death before 28 days of age

    Within 28 days of birth

Study Arms (2)

Ugandan mother-baby cohort

Mother-baby pairs recruited antenatally or at delivery, with babies eligible for inclusion if they are born at 34 weeks gestational age and above. Used as primary data for modelling.

Other: Maternal medical history

Zimbabwean mother-baby cohort

Mother-baby pairs with babies eligible for inclusion if they are born at 34 weeks gestational age and above, used as a validation cohort for the model.

Other: Maternal medical history

Interventions

See above; multiple factors to be collected broadly grouped into maternal medical, obstetric, and sociodemographic/lifestyle factors.

Also known as: Maternal obstetric/pregnancy history, Maternal sociodemographic/lifestyle factors
Ugandan mother-baby cohortZimbabwean mother-baby cohort

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study populations will be recruited from Kawempe National Referral Hospital in Kampala, Uganda and Sally Mugabe Central Hospital in Harare, Zimbabwe.

You may qualify if:

  • Neonates born at one of the study sites
  • Neonates born at ≥34 weeks gestational age, defined by:
  • Ultrasound scan, where participant has had an ultrasound scan during routine antenatal care
  • If no ultrasound scan has been done, according to last menstrual period date, according to mother

You may not qualify if:

  • Neonates born at \<34 weeks gestational age, due to their higher background risk of sepsis, and automatic admission to the neonatal unit with antibiotic administration
  • Neonates with congenital abnormalities or syndromes associated with increased susceptibility to infection will be excluded (e.g. gastroschisis).
  • Neonates whose mothers are unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Makerere University, John Hopkins University

Kawempe, Uganda

RECRUITING

St George's, University of London

London, SW17 0RE, United Kingdom

NOT YET RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Dried blood spots will be retained for any samples where there is leftover sample

MeSH Terms

Conditions

Neonatal Sepsis

Interventions

Reproductive History

Condition Hierarchy (Ancestors)

SepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Medical History TakingDiagnostic Techniques and ProceduresDiagnosisEpidemiologic FactorsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2024

First Posted

May 13, 2024

Study Start

April 11, 2024

Primary Completion

December 31, 2024

Study Completion

March 1, 2025

Last Updated

May 17, 2024

Record last verified: 2024-02

Locations